Does TREPROSTINIL Cause Respiratory tract infection? 204 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Respiratory tract infection have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.
204
Reports of Respiratory tract infection with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
15
Deaths
110
Hospitalizations
How Dangerous Is Respiratory tract infection From TREPROSTINIL?
Of the 204 reports, 15 (7.4%) resulted in death, 110 (53.9%) required hospitalization, and 4 (2.0%) were considered life-threatening.
Is Respiratory tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 204 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Respiratory tract infection?
RITUXIMAB (1,058)
PREDNISONE (1,051)
OMALIZUMAB (927)
ADALIMUMAB (913)
METHOTREXATE (895)
ETANERCEPT (848)
HUMAN IMMUNOGLOBULIN G (764)
LENALIDOMIDE (731)
DEXAMETHASONE (684)
ALBUTEROL (601)
Which TREPROSTINIL Alternatives Have Lower Respiratory tract infection Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE